Condition: Obesity · Overweight · Sponsor: Eli Lilly and Company
The purpose of this study is to evaluate the efficacy and safety of eloralintide in adults with obesity or overweight who do not have type 2 diabetes. The study has two phases: a main phase and an extension phase. Participation in the main phase of the study will last about 75 weeks. Participants with prediabetes will continue in the extension phase for another 2 years.
This description comes directly from the study's public registry record.
Trial question or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| MFA Clinical Research | Tuscaloosa, Alabama, United States | Recruiting |
| Headlands Research - Scottsdale | Scottsdale, Arizona, United States | Recruiting |
| Neighborhood Healthcare Institute of Health | Escondido, California, United States | Recruiting |
| Ark Clinical Research - Fountain Valley | Fountain Valley, California, United States | Recruiting |
| Desert Oasis Healthcare Medical Group | Palm Springs, California, United States | Recruiting |
| Peninsula Research Associates | Rolling Hills Estates, California, United States | Recruiting |
| Care Access - Sacramento | Sacramento, California, United States | Recruiting |
| Southern California Clinical Research | Santa Ana, California, United States | Recruiting |
| University Clinical Investigators, Inc. | Tustin, California, United States | Recruiting |
| Chase Medical Research, LLC | Waterbury, Connecticut, United States | Recruiting |
| JEM Research Institute | Atlantis, Florida, United States | Recruiting |
| BioMed Research & Medical Center | Miami, Florida, United States | Recruiting |
+ 150 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07321886